SCHEMBL20897934

SCHEMBL20897934

Fc1cc(Cl)cc(F)c1C=C1CCNCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 13/20 0.43
▸ HTR2B P41595 12/20 0.43
▸ HTR2A P28223 11/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.36
▸ HRH4 Q9H3N8 1/20 0.35
▸ PNMT P11086 1/20 0.34
▸ ADRB1 P08588 2/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ HRH1 P35367 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ ASIC3 Q9UHC3 1/20 0.33
▸ CHRM2 P08172 1/20 0.32
▸ CHRM4 P08173 1/20 0.32
▸ CHRM1 P11229 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20897971 0.98 HTR2C (0.42) HTR2CHTR2BHTR2AHRH3HRH4
SCHEMBL20897963 0.79 PRKACA (0.39) HTR2CHTR2BHTR2AHRH3PNMT
SCHEMBL20898260 0.77 HTR2C (0.49) HTR2CHTR2BHTR2AHRH3HRH4
Hydrochloric Acid SCHEMBL20897928 0.77 PRKACA (0.38) HTR2CHTR2BHTR2AHRH3PNMT
Hydrochloric Acid SCHEMBL16322269 0.76 HTR2C (0.47) HTR2CHTR2BHTR2AHRH4PNMT
SCHEMBL20897973 0.70 SRD5A2 (0.38) HRH4
SCHEMBL20897988 0.69 BTK (0.42) HTR2AHRH4HTR1A
SCHEMBL15566395 0.69 NFE2L2 (0.42) HTR2CHTR2BHTR2AHRH3
Hydrochloric Acid SCHEMBL459695 0.68 NFE2L2 (0.41) HTR2CHTR2BHTR2AHRH3
SCHEMBL22265795 0.67 HRH3 (0.39) HTR2CHTR2BHTR2AHRH3ADCY6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019072978-A1 MITOCHONDRIAL INHIBITORS FOR THE TREATMENT OF PROLIFERATION DISORDERS Basilea Pharmaceutica International AG (CH) 2019-04-18 — — WO disclosed
Send feedback